PDT Partners’s GenMark Diagnostics, Inc GNMK Stock Holding History

PDT Partners’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-43,953	Closed	-$1.05M	–	1016
2021 Q1	$1.05M	Sell	43,953 -142,418	-76%	-$2.65M	0.08%	366
2020 Q4	$2.72M	Buy	186,371 +36,654	+24%	+$486K	0.18%	215
2020 Q3	$2.13M	Sell	149,717 -46,523	-24%	-$711K	0.14%	209
2020 Q2	$2.89M	Buy	196,240 +141,140	+256%	+$1.43M	0.2%	170
2020 Q1	$227K	Buy	55,100 +12,600	+30%	+$59.1K	0.02%	533
2019 Q4	$204K	Buy	42,500 +6,500	+18%	+$35.9K	0.01%	645
2019 Q3	$218K	Hold	36,000	–	–	0.01%	404
2019 Q2	$234K	Hold	36,000	–	–	0.01%	356
2019 Q1	$255K	Sell	36,000 -9,400	-21%	-$61.9K	0.01%	370
2018 Q4	$221K	Buy	45,400 +10,279	+29%	+$53.5K	0.01%	394
2018 Q3	$258K	Buy	+35,121	New	+$258K	0.01%	412
2015 Q4	–	Sell	-29,569	Closed	-$233K	–	1082
2015 Q3	$233K	Buy	+29,569	New	+$273K	0.01%	1111
2013 Q3	–	Sell	-13,600	Closed	-$141K	–	1792
2013 Q2	$141K	Buy	+13,600	New	+$188K	﹤0.01%	1419

PDT Partners's GNMK Position: Q2 2021 in Review

PDT Partners sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 43,953 shares — an estimated $1.05M sold.

PDT Partners first reported a position in GNMK in Q2 2013 and held it in 13 quarters. The position peaked at $2.89M in Q2 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

PDT Partners reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
PDT Partners sold 43,953 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $1.05M.
PDT Partners first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 13 quarters.
PDT Partners's GenMark Diagnostics, Inc position peaked at $2.89M in Q2 2020.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on PDT Partners's 13F filing for Q2 2021, filed 16 Aug 2021.